LifeSemantics Corp. (347700) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of LifeSemantics Corp. KRW 2,310, price KRW 23,300, upside -90.1%, quality 36 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Structural break:
The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.
Weakest SetupStrongly overvalued and low quality.
!Fair value 2,310 KRW · Strongly overvalued (−90%)
!Quality 36/100
!Expensive Growth(revenue 5y +104.6 %/yr)
✓Highly profitable · 30.9% net margin (TTM)
!Low debt · negative free cash flow
✓Ranks above peers(5/8)
!Moderate moat59/100
!Evidence only low, so the estimate is less certain
Watch LifeSemantics Corp. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Sphere Corp. provides digital healthcare technology, and life care products and services. It develops LifeRecord, a commercial personal health record platform that manages health-related data, including medical records, genome data, and personally generated health data.
Show more
Sphere Corp. provides digital healthcare technology, and life care products and services. It develops LifeRecord, a commercial personal health record platform that manages health-related data, including medical records, genome data, and personally generated health data. The company also offers digital healthcare services for consumers, such as non-face-to-face treatment, medication management, and health management, as well as patient communities with digital health enablement comprising digital therapeutics and software-based medical devices using artificial intelligence technology. In addition, it provides consumer medical devices used at home; medical devices and equipment for use in healthcare facilities; and other consumer goods. The company was formerly known as LifeSemantics Corp. and changed its name to Sphere Corp. in April 2025. The company was founded in 2012 and is based in Seoul, South Korea.
Stock analysis
LifeSemantics Corp. (347700) currently trades at 23,300 KRW, while our model-based Fair Value estimate is 2,310 KRW, implying the stock looks roughly 909.1% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 3,081 KRW per share, and 0 of the 15 models we run sit above the 23,300 KRW price.
Bear case: the Economic Profit group reads lowest at 842.20 KRW, and 15 of the 15 models stay below the price. Evidence for this calculation is low.
Scenario range: 1,044 KRW (bear) to 2,982 KRW (bull), the price of 23,300 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
LifeSemantics Corp. reported revenue of 95.6B KRW in FY2025 versus 4.6B KRW in FY2021, a compound +113.1%/yr. Reported net income was 170M KRW in FY2025.
Key figures
Market cap 826B KRW (≈ $578M) · P/S ratio 15.2 · Net margin 0.2% · Return on equity 54.7% · Return on assets (EBIT) −22.0% · Operating margin 1.6% · Revenue (TTM) 119B KRW · Revenue growth (YoY) +106%.
What moves the price
The share trades about 59% below its 52-week high and 230% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at −90%, 347700 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (61.56 KRW to 3,362 KRW). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear 1,044 KRWFair Value 2,310 KRWBull 2,982 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+3,639.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+223.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+104.6%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+58.5%
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−144.4% (2020) → 9.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 132 stocks
Beats the industry median on 4/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score36 · Bottom 25%
Fair Value upside−90% · Bottom 25%
Profitability
Return on equity (TTM)55% · Top 25%
Return on assets1% · Above median
Net margin (TTM)31% · Top 25%
Operating margin (TTM)2% · Below median
Growth and dividend
Revenue growth106% · Top 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 36
PAST (return on equity)100· sector 7
HEALTH (low debt)100· sector 98
DIVIDEND (yield)0· sector 49
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "LifeSemantics Corp. Fair Value". https://www.fairvalue-calculator.com/stock/347700
Frequently asked questions
Is LifeSemantics Corp. (347700) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 2,310 KRW versus a price of 23,300 KRW, about −90% upside (overvalued).
What is the fair value of 347700?
Our model-based fair value for LifeSemantics Corp. is 2,310 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 23,300 KRW.
What is the quality score of 347700?
LifeSemantics Corp. has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for LifeSemantics Corp. (347700)?
Our model-based price target is the fair value of 2,310 KRW (as of Sep 24, 2026) from 15 valuation models. Cautious scenario 1,044 KRW, optimistic scenario 2,982 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the LifeSemantics Corp. stock forecast for 2026?
Our models put fair value at 2,310 KRW, about −90% upside versus a price of 23,300 KRW (overvalued). Cautious scenario 1,044 KRW, optimistic scenario 2,982 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of LifeSemantics Corp. (347700)?
LifeSemantics Corp. reported trailing-twelve-month revenue of about 119B KRW (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of LifeSemantics Corp. (347700)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For LifeSemantics Corp. it is 2,310 KRW per share (as of Sep 24, 2026), against a price of 23,300 KRW. It is the blended result of 15 valuation models (cash flow, earnings, asset, dividend).
Is LifeSemantics Corp. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 347700 trades above its calculated fair value: price 23,300 KRW, fair value 2,310 KRW, a gap of about −90% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 347700?
No. The price is what the market pays today (23,300 KRW); the fair value is what the company's own numbers justify (2,310 KRW). For LifeSemantics Corp. the two are 20,990 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is LifeSemantics Corp. worth?
The market values LifeSemantics Corp. at about 826B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 23,300 KRW; our models calculate a fair value of 2,310 KRW per share.
What do the bullish and bearish scenarios say about 347700?
Our models span a range for LifeSemantics Corp.: cautious scenario 1,044 KRW, base 2,310 KRW, optimistic 2,982 KRW per share (as of Sep 24, 2026, price 23,300 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of LifeSemantics Corp. (347700)?
Balance-sheet figures for LifeSemantics Corp. (as of Sep 24, 2026): return on equity 54.7%. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is 347700 from its 52-week high?
LifeSemantics Corp. trades at 23,300 KRW, about 59% below its 52-week high of 57,300 KRW and 230% above the low of 7,050 KRW (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 2,310 KRW is for.
Which stocks are comparable to LifeSemantics Corp.?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is LifeSemantics Corp. stock attractive at the current price?
The data as of Sep 24, 2026: price 23,300 KRW, calculated fair value 2,310 KRW (−90%), Quality Score 36/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 347700 calculated?
We run LifeSemantics Corp. through 15 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 2,310 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. LifeSemantics Corp. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of LifeSemantics Corp. (347700)?
The closing price on Sep 23, 2026 was 23,300 KRW. Our model-based fair value is 2,310 KRW, about −90% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with LifeSemantics Corp. right now?
The price sits above even our optimistic bull case (2,982 KRW). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (1,044 KRW to 2,982 KRW). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of LifeSemantics Corp.
How large is the market capitalisation of LifeSemantics Corp. (347700)?
The market capitalisation of LifeSemantics Corp. is 826B KRW (≈ $578M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of LifeSemantics Corp. (347700)?
The price-to-sales ratio of LifeSemantics Corp. is 15.2 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of LifeSemantics Corp. (347700)?
The net margin of LifeSemantics Corp. is 0.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of LifeSemantics Corp. (347700)?
The return on equity (ROE) of LifeSemantics Corp. is 54.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of LifeSemantics Corp. (347700)?
On an EBIT basis the return on assets of LifeSemantics Corp. is −22.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of LifeSemantics Corp. (347700)?
The operating margin of LifeSemantics Corp. is 1.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at LifeSemantics Corp. (347700)?
Revenue at LifeSemantics Corp. is growing +106% versus a year earlier (3y avg +224%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at LifeSemantics Corp. (347700)?
Earnings per share at LifeSemantics Corp. are growing +568% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does LifeSemantics Corp. (347700) generate?
The free cash flow of LifeSemantics Corp. is −14.7B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does LifeSemantics Corp. (347700) carry?
The net debt of LifeSemantics Corp. is 8.2B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch LifeSemantics Corp. in the live analysis
One click puts LifeSemantics Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
